PDF
Abstract
Acute respiratory distress syndrome (ARDS) is one of the most fatal diseases worldwide. Pulmonary fibrosis occurs early in ARDS, and its severity plays a crucial role in ARDS mortality rate. Some studies suggested that fibroproliferation is an essential mechanism in ARDS. Mitofusion2 (Mfn2) overexpression plays a role in inhibiting cell proliferation. However, the role and potential mechanism of Mfn2 on the proliferation of fibroblasts is still unknown. In this study, we aimed at exploring the effect of Mfn2 on the human embryonic lung fibroblasts (HELF) and discussed its related mechanism. The HELF were treated with the Mfn2 overexpressing lentivirus (adv-Mfn2). The cell cycle was detected by flow cytometry. MTT, PCR and Western blotting were used to investigate the effect of Mfn2 on the proliferation of the HELF, collagen expression, the RAS-RAF-1-ERK1/2 pathway and the expression of cycle-related proteins (p21, p27, Rb, Raf-1, p-Raf-1, Erk1/2 and p-Erk1/2). The co-immunoprecipitation assay was used to explore the interaction between Mfn2 and Ras. The results showed that the overexpression of Mfn2 inhibited the proliferation of the HELF and induced the cell cycle arrest at the G0/G1 phase. Meanwhile, Mfn2 also inhibited the expression of collagen I, p-Erk and p-Raf-1. In addition, an interaction between Mfn2 and Ras existed in the HELF. This study suggests that the overexpression of Mfn2 can decrease the proliferation of HELF in ARDS, which was associated with the inhibition of the RAS-RAF-1-ERK1/2 pathway. The results may offer a potential therapeutic intervention for patients with ARDS.
Keywords
Mitofusion2
/
human embryonic lung fibroblasts
/
acute respiratory distress syndrome
/
RAS-RAF-1-ERK1/2 pathway
Cite this article
Download citation ▾
Juan Li, Mei-xia Xu, Zhong Dai, Tao Xu.
Mitofusion 2 Overexpression Decreased Proliferation of Human Embryonic Lung Fibroblasts in Acute Respiratory Distress Syndrome through Inhibiting RAS-RAF-1-ERK1/2 Pathway.
Current Medical Science, 2021, 40(6): 1092-1098 DOI:10.1007/s11596-020-2305-y
| [1] |
PhuaJ, BadiaJR, AdhikariNK, et al.. Has mortality from acute respiratory distress syndrome decreased over time?: A systematic review. Am J Respir Crit Care Med, 2009, 179(3): 220-227
|
| [2] |
VillarJ, Pérez-MéndezL, BlancoJ, et al.. A universal definition of ARDS: the PaO2/FiO2 ratio under a standard ventilatory setting—a prospective, multicenter validation study. Intensive Care Med, 2013, 39(4): 583-592
|
| [3] |
Silasi-MansatR, ZhuH, GeorgescuC. Complement inhibition decreases early fibrogenic events in the lung of septic baboons. J Cell Mol Med, 2015, 19(11): 2549-2563
|
| [4] |
SweeneyRM, McAuleyDF. Acute respiratory distress syndrome. Lancet, 2016, 388(12): 2416-2430
|
| [5] |
BurnhamEL, JanssenWJ, RichesDW, et al.. The fibroproliferative response in acute respiratory distress syndrome: mechanisms and clinical significance. Eur Respir J, 2014, 43(1): 276-285
|
| [6] |
SchrepferE, ScorranoL. Mitofusins, from Mitochondria to Metabolism. Mol Cell, 2016, 61(5): 683-694
|
| [7] |
ChenKH, GuoX, MaD, et al.. Dysregulation of HSG triggers vascular proliferative disorders. Nat Cell Biol, 2004, 6(9): 872-883
|
| [8] |
GuoXM, ChenKH, GuoYH, et al.. Mitofusin 2 triggers vascular smooth muscle cell apoptosis via mitochondrial death pathway. Circ Res, 2007, 101(11): 1113-1122
|
| [9] |
LiaoH, GongJ, ZhangW, et al.. Valsartan inhibits angiotensin II -induced proliferation of vascular smooth muscle cells via regulating the expression of mitofusin 2. J Huazhong Univ Sci Technolog Med Sci, 2012, 32(1): 31-35
|
| [10] |
RyanJ, DasguptaA, HustonJ, et al.. Mitochondrial dynamics in pulmonary arterial hypertension. J Mol Med (Berl), 2015, 93(3): 229-242
|
| [11] |
KannanA, WellsRB, SivakumarS. Mitochondrial Reprogramming Regulates Breast Cancer Progression. Clin Cancer Res, 2016, 22(13): 3348-3360
|
| [12] |
SunM, YuH, ZhangY, et al.. MicroRNA-214 Mediates Isoproterenol-induced Proliferation and Collagen Synthesis in Cardiac Fibroblasts. Sci Rep, 2015, 22(5): 18
|
| [13] |
SchuligaMJ, SeeI, OngSC, et al.. Fibrillar collagen clamps lung mesenchymal cells in a nonproliferative and noncontractile phenotype. Am J Respir Cell Mol Biol, 2009, 41(6): 731-741
|
| [14] |
PolyakK, LeeMH, Erdjument-BromageH, et al.. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell, 1994, 78: 59-66
|
| [15] |
LiY, LiangJ, YangT, et al.. Hyaluronan synthase 2 regulates fibroblast senescence in pulmonary fibrosis. Matrix Biol, 2016, 55: 35-48
|
| [16] |
ChienKR, HoshijimaM. Unravelling Ras signals in cardiovascular disease. Nat Cell Biol, 2004, 6(9): 807-808
|
| [17] |
ChenKH, DasguptaA, DingJ, et al.. Role of mitofusin 2 (Mfn2) in controlling cellular proliferation. FASEB J, 2014, 28: 382-394
|
| [18] |
ZhangGE, JinHL, LinXK, et al.. Anti-tumor effects of mfn2 in gastric cancer. Int J Mol Sci, 2013, 14: 13 005-13 021
|
| [19] |
ForelJM, GuervillyC, HraiechS, et al.. Type III procollagen is a reliable marker of ARDS-associated lung fibroproliferation. Intensive Care Med, 2015, 41(1): 1-11
|
| [20] |
HendricksonCM, CrestaniB, MatthayMA. Biology and pathology of fibroproliferation following the acute respiratory distress syndrome. Intensive Care Med, 2015, 41(1): 147-150
|
| [21] |
MeduriGU, EltorkyMA. Understanding ARDS-associated fibroproliferation. Intensive Care Med, 2015, 41(3): 517-520
|
| [22] |
MontagnoliA, FioreF, EytanE, et al.. Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation. Genes Dev, 1999, 13(9): 1181-1189
|